Clarivate, the  global leader in trusted and transformative intelligence has today announced its 2023 highly cited researchers.

Today, for the first time a virtual reality treatment (VR) has been recommended for use in NHS mental health services.

Health Innovation Oxford and Thames Valley have published a case study on their involvement in the development of a dementia diagnostic called FSL, a software platform which can extract metrics from brain scans.

Developments and improvements to the treatment and knowledge of conditions including depression, dementia and psychosis were in the spotlight at a recent event in Oxford.

An Oxford grandfather taking part in a research trial into whether a new weight loss drug can help Alzheimer’s patients has urged others to consider joining studies.

New research shows the link between sleep and psychosis in young people at high risk of psychosis and highlights the importance of effective psychological treatment.

Oxford Health plays a leading role in £42.7m research effort to find innovative new treatments for mental illness

A data scientist who was able to return to work after taking medication for severe depression as part of a research trial has urged others to consider taking part in studies to shape the future of healthcare.

Research into bipolar disorder at Oxford has received a major boost following a £3 million donation from the Page family. The legacy gift will support the development of innovative new treatments as well as improved methods of self-management for those with the condition.

Innovative treatments and transformative therapies in brain health are on the horizon thanks to a £35.4 million award to the NIHR Oxford Health Biomedical Research Centre.